首页 > 最新文献

Materia socio-medica最新文献

英文 中文
The Influence of Gender and Length of Therapy Use on Sleep Quality in Patients with Parkinson's Disease. 性别和治疗时间对帕金森病患者睡眠质量的影响
Pub Date : 2025-01-01 DOI: 10.5455/msm.2025.37.58-63
Zikrija Dostovic, Nermin Mesic, Nerimana Suljkanovic, Denisa Salihovic

Background: Normal sleep duration is crucial for maintaining brain homeostasis. Sleep disorders in Parkinson's disease are numerous, multifactorial, and result in significant morbidity.

Objective: The aim of the study was to investigate the association between gender and the duration of therapy on sleep quality in patients with Parkinson's disease.

Methods: The study is prospective, and includes 40 consecutively hospitalized patients with verified Parkinson's disease. The study included subjects of both genders and all age groups. To analyze the data on the subjects, we used: medical histories, nursing documentation of patients, a questionnaire with sociodemographic data, and the Parkinson's Disease Sleep Assessment Scale. We divided all subjects into two groups: subjects who have been using therapy for up to 5 years and those who have been using therapy for more than 5 years.

Results: Among subjects who have been taking medication for less than 5 years, 33.3% were female and 66.6% were male. Of the total number of respondents who have been taking therapy for more than 5 years, 36.3% are female and 63.6% are male. The duration of the therapy has a statistically significant effect on the quality of sleep in patients with Parkinson's disease (p < 0.05). The subject's gender does not have a significant independent influence on the quality of sleep in patients with Parkinson's disease (p > 0.05). The interaction of gender and length of therapy use has no significant separate effect on the quality of sleep in Parkinson's disease patients (p > 0.05). The quality of sleep is better in male and female subjects who take the therapy until the age of 5.

Conclusion: The duration of therapy use has a significant impact on the quality of sleep in Parkinson's disease patients. The gender of the subject has no significant independent influence on the quality of sleep in patients with Parkinson's disease.

背景:正常的睡眠时间对维持大脑平衡至关重要。帕金森病患者的睡眠障碍种类繁多,由多种因素导致,发病率高:本研究旨在探讨帕金森病患者的性别和治疗时间对睡眠质量的影响:本研究为前瞻性研究,包括 40 名连续住院的已确诊帕金森病患者。研究对象包括男女老少。为了分析受试者的数据,我们采用了以下方法:病史、患者护理记录、社会人口学数据问卷以及帕金森病睡眠评估量表。我们将所有受试者分为两组:接受治疗时间不超过 5 年的受试者和接受治疗时间超过 5 年的受试者:在接受药物治疗不足 5 年的受试者中,33.3% 为女性,66.6% 为男性。在接受治疗超过 5 年的受访者中,女性占 36.3%,男性占 63.6%。治疗时间的长短对帕金森病患者的睡眠质量有显著的统计学影响(P < 0.05)。受试者的性别对帕金森病患者的睡眠质量没有明显的独立影响(P > 0.05)。性别与治疗时间的交互作用对帕金森病患者的睡眠质量没有明显的单独影响(P > 0.05)。在 5 岁之前接受治疗的男性和女性受试者的睡眠质量更好:结论:治疗持续时间对帕金森病患者的睡眠质量有显著影响。受试者的性别对帕金森病患者的睡眠质量没有明显的独立影响。
{"title":"The Influence of Gender and Length of Therapy Use on Sleep Quality in Patients with Parkinson's Disease.","authors":"Zikrija Dostovic, Nermin Mesic, Nerimana Suljkanovic, Denisa Salihovic","doi":"10.5455/msm.2025.37.58-63","DOIUrl":"10.5455/msm.2025.37.58-63","url":null,"abstract":"<p><strong>Background: </strong>Normal sleep duration is crucial for maintaining brain homeostasis. Sleep disorders in Parkinson's disease are numerous, multifactorial, and result in significant morbidity.</p><p><strong>Objective: </strong>The aim of the study was to investigate the association between gender and the duration of therapy on sleep quality in patients with Parkinson's disease.</p><p><strong>Methods: </strong>The study is prospective, and includes 40 consecutively hospitalized patients with verified Parkinson's disease. The study included subjects of both genders and all age groups. To analyze the data on the subjects, we used: medical histories, nursing documentation of patients, a questionnaire with sociodemographic data, and the Parkinson's Disease Sleep Assessment Scale. We divided all subjects into two groups: subjects who have been using therapy for up to 5 years and those who have been using therapy for more than 5 years.</p><p><strong>Results: </strong>Among subjects who have been taking medication for less than 5 years, 33.3% were female and 66.6% were male. Of the total number of respondents who have been taking therapy for more than 5 years, 36.3% are female and 63.6% are male. The duration of the therapy has a statistically significant effect on the quality of sleep in patients with Parkinson's disease (p < 0.05). The subject's gender does not have a significant independent influence on the quality of sleep in patients with Parkinson's disease (p > 0.05). The interaction of gender and length of therapy use has no significant separate effect on the quality of sleep in Parkinson's disease patients (p > 0.05). The quality of sleep is better in male and female subjects who take the therapy until the age of 5.</p><p><strong>Conclusion: </strong>The duration of therapy use has a significant impact on the quality of sleep in Parkinson's disease patients. The gender of the subject has no significant independent influence on the quality of sleep in patients with Parkinson's disease.</p>","PeriodicalId":94128,"journal":{"name":"Materia socio-medica","volume":"37 1","pages":"58-63"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11910904/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143652883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Community-Acquired Bacterial Meningitis in Tuzla Canton (2014-2024): An 11-Year Retrospective Analysis of Clinical Features, Pathogens, and Prognostic Factors. 图兹拉州社区获得性细菌性脑膜炎(2014-2024):临床特征、病原体和预后因素的11年回顾性分析
Pub Date : 2025-01-01 DOI: 10.5455/msm.2025.37.205-212
Humera Porobic-Jahic, Rahima Jahic, Dilista Piljic, Jasminka Petrovic, Alma Trnacevic, Sehveta Mustafic, Danijel Bijedic, Nijaz Tihic, Denis Zepic, Azra Zigic

Background: Community-acquired bacterial meningitis (CABM) remains a life-threatening infection with high morbidity and mortality, despite advances in antibiotic therapy and vaccination. Understanding local epidemiology is crucial for improving outcomes.

Objective: To evaluate clinical and epidemiological characteristics and outcome of patients with bacterial meningitis in all age groups.

Methods: This retrospective study analyzed 78 cases of CABM treated at the University Clinical Center Tuzla from 2014 to 2024. Patients were divided by age and outcome. Clinical features, laboratory results, microbiological findings, and prognostic factors were examined.

Results: Adults comprised 59% of cases, and children 41%, with a median age of 29 years. The most common symptoms were fever (91%), positive meningeal signs (76.9%), vomiting (69.2%), and headache (66.7%). Streptococcus pneumoniae (24.4%) and Neisseria meningitidis (14.1%) were the leading pathogens. Mortality was 14.1%, significantly higher in adults (19.6%) than in children (6.3%). Poor outcomes were associated with older age, coma, ICU admission, and complications such as cerebral abscess or shock. Laboratory indicators of worse prognosis included thrombocytopenia, elevated urea and creatinine, hypokalemia, and low CSF cell count.

Conclusion: CABM remains a serious clinical problem in Tuzla Canton. Early recognition, appropriate empiric antibiotic treatment, ICU management, and preventive measures such as vaccination are essential for improving survival, particularly in high-risk populations.

背景:尽管抗生素治疗和疫苗接种取得了进展,但社区获得性细菌性脑膜炎(CABM)仍然是一种危及生命的感染,发病率和死亡率都很高。了解当地流行病学对改善结果至关重要。目的:评价各年龄组细菌性脑膜炎患者的临床、流行病学特点及转归。方法:回顾性分析2014年至2024年图兹拉大学临床中心收治的78例CABM病例。患者按年龄和结果进行分组。检查临床特征、实验室结果、微生物学结果和预后因素。结果:成人占59%,儿童占41%,中位年龄29岁。最常见的症状为发热(91%)、脑膜阳性征象(76.9%)、呕吐(69.2%)和头痛(66.7%)。肺炎链球菌(24.4%)和脑膜炎奈瑟菌(14.1%)是主要致病菌。死亡率为14.1%,成人(19.6%)显著高于儿童(6.3%)。不良预后与年龄较大、昏迷、ICU住院以及脑脓肿或休克等并发症相关。预后较差的实验室指标包括血小板减少、尿素和肌酐升高、低钾血症和低脑脊液细胞计数。结论:CABM在图兹拉州仍是一个严重的临床问题。早期识别、适当的经验性抗生素治疗、ICU管理和预防措施(如接种疫苗)对于提高生存率至关重要,特别是在高危人群中。
{"title":"Community-Acquired Bacterial Meningitis in Tuzla Canton (2014-2024): An 11-Year Retrospective Analysis of Clinical Features, Pathogens, and Prognostic Factors.","authors":"Humera Porobic-Jahic, Rahima Jahic, Dilista Piljic, Jasminka Petrovic, Alma Trnacevic, Sehveta Mustafic, Danijel Bijedic, Nijaz Tihic, Denis Zepic, Azra Zigic","doi":"10.5455/msm.2025.37.205-212","DOIUrl":"10.5455/msm.2025.37.205-212","url":null,"abstract":"<p><strong>Background: </strong>Community-acquired bacterial meningitis (CABM) remains a life-threatening infection with high morbidity and mortality, despite advances in antibiotic therapy and vaccination. Understanding local epidemiology is crucial for improving outcomes.</p><p><strong>Objective: </strong>To evaluate clinical and epidemiological characteristics and outcome of patients with bacterial meningitis in all age groups.</p><p><strong>Methods: </strong>This retrospective study analyzed 78 cases of CABM treated at the University Clinical Center Tuzla from 2014 to 2024. Patients were divided by age and outcome. Clinical features, laboratory results, microbiological findings, and prognostic factors were examined.</p><p><strong>Results: </strong>Adults comprised 59% of cases, and children 41%, with a median age of 29 years. The most common symptoms were fever (91%), positive meningeal signs (76.9%), vomiting (69.2%), and headache (66.7%). Streptococcus pneumoniae (24.4%) and Neisseria meningitidis (14.1%) were the leading pathogens. Mortality was 14.1%, significantly higher in adults (19.6%) than in children (6.3%). Poor outcomes were associated with older age, coma, ICU admission, and complications such as cerebral abscess or shock. Laboratory indicators of worse prognosis included thrombocytopenia, elevated urea and creatinine, hypokalemia, and low CSF cell count.</p><p><strong>Conclusion: </strong>CABM remains a serious clinical problem in Tuzla Canton. Early recognition, appropriate empiric antibiotic treatment, ICU management, and preventive measures such as vaccination are essential for improving survival, particularly in high-risk populations.</p>","PeriodicalId":94128,"journal":{"name":"Materia socio-medica","volume":"37 3","pages":"205-212"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12858268/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146108848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of the Impact of Independent Factors on the Score - Mental Health Scale of the SF-36 Questionnaire in Hypertensive Patients Who Recovered from COVID-19. 独立因素对新冠肺炎康复期高血压患者SF-36心理健康量表得分的影响分析
Pub Date : 2025-01-01 DOI: 10.5455/msm.2025.37.231-235
Samela Zelic, Ediba Celic-Spuzic, Senada Dzebo, Hasiba Erkocevic, Natasa Trifunovic, Adnan Cejvan, Amra Macic-Dzankovic

Background: The COVID-19 pandemic has significantly affected people's lifestyles, particularly influencing existing chronic conditions such as hypertension. It is estimated that 1.28 billion adults aged 30-79 worldwide have hypertension. In addition to its impact on blood pressure levels, the pandemic also affected the quality of life and mental health of hypertensive patients. Mental health among individuals with chronic diseases who have recovered from COVID-19 is an important and complex issue. Research indicates that these patients are at a considerably higher risk of developing anxiety, depression, and PTSD, as well as experiencing deterioration of their underlying conditions.

Objective: The aim of this study was to analyze the impact of independent factors on the mental health score using the SF-36 questionnaire among hypertensive patients who recovered from COVID-19.

Methods: A cross-sectional study was conducted in selected primary healthcare centers across four cantons in the Federation of Bosnia and Herzegovina (FBiH). The study included a total of 240 patients, randomly selected from those diagnosed with hypertension who had recovered from COVID-19 (experimental group, n = 120). The control group consisted of 120 participants who had recovered from COVID-19 but did not have hypertension. The European SF-36 questionnaire was used for longitudinal self-assessment of health status in patients with various chronic conditions.

Results: The analysis of independent factors affecting mental health during the COVID-19 pandemic showed poorer mental health outcomes among older, single participants with higher educational attainment. In relation to COVID-19 treatment, patients who had been hospitalized or treated in Intensive Care Units and who experienced cardiac complications exhibited worse mental health scores.

Conclusion: The findings of this study indicate a statistically significant higher likelihood of poorer mental health among hypertensive patients who had contracted COVID-19.

背景:COVID-19大流行严重影响了人们的生活方式,特别是对高血压等现有慢性疾病的影响。据估计,全世界有12.8亿30-79岁的成年人患有高血压。除了影响血压水平外,大流行还影响了高血压患者的生活质量和心理健康。从COVID-19中康复的慢性病患者的心理健康是一个重要而复杂的问题。研究表明,这些患者患焦虑、抑郁和创伤后应激障碍的风险相当高,而且他们的潜在疾病也会恶化。目的:利用SF-36问卷分析独立因素对新冠肺炎康复期高血压患者心理健康评分的影响。方法:在波斯尼亚和黑塞哥维那联邦(FBiH)四个州的选定初级保健中心进行了横断面研究。本研究共纳入240例新冠肺炎康复的高血压患者(实验组,n = 120)。对照组由120名从COVID-19中康复但没有高血压的参与者组成。采用欧洲SF-36问卷对不同慢性疾病患者的健康状况进行纵向自我评估。结果:对COVID-19大流行期间影响心理健康的独立因素的分析显示,年龄较大、受教育程度较高的单身参与者的心理健康状况较差。在COVID-19治疗方面,住院或在重症监护病房接受治疗以及患有心脏并发症的患者表现出更差的心理健康评分。结论:本研究结果表明,在感染COVID-19的高血压患者中,心理健康状况较差的可能性具有统计学意义。
{"title":"Analysis of the Impact of Independent Factors on the Score - Mental Health Scale of the SF-36 Questionnaire in Hypertensive Patients Who Recovered from COVID-19.","authors":"Samela Zelic, Ediba Celic-Spuzic, Senada Dzebo, Hasiba Erkocevic, Natasa Trifunovic, Adnan Cejvan, Amra Macic-Dzankovic","doi":"10.5455/msm.2025.37.231-235","DOIUrl":"10.5455/msm.2025.37.231-235","url":null,"abstract":"<p><strong>Background: </strong>The COVID-19 pandemic has significantly affected people's lifestyles, particularly influencing existing chronic conditions such as hypertension. It is estimated that 1.28 billion adults aged 30-79 worldwide have hypertension. In addition to its impact on blood pressure levels, the pandemic also affected the quality of life and mental health of hypertensive patients. Mental health among individuals with chronic diseases who have recovered from COVID-19 is an important and complex issue. Research indicates that these patients are at a considerably higher risk of developing anxiety, depression, and PTSD, as well as experiencing deterioration of their underlying conditions.</p><p><strong>Objective: </strong>The aim of this study was to analyze the impact of independent factors on the mental health score using the SF-36 questionnaire among hypertensive patients who recovered from COVID-19.</p><p><strong>Methods: </strong>A cross-sectional study was conducted in selected primary healthcare centers across four cantons in the Federation of Bosnia and Herzegovina (FBiH). The study included a total of 240 patients, randomly selected from those diagnosed with hypertension who had recovered from COVID-19 (experimental group, n = 120). The control group consisted of 120 participants who had recovered from COVID-19 but did not have hypertension. The European SF-36 questionnaire was used for longitudinal self-assessment of health status in patients with various chronic conditions.</p><p><strong>Results: </strong>The analysis of independent factors affecting mental health during the COVID-19 pandemic showed poorer mental health outcomes among older, single participants with higher educational attainment. In relation to COVID-19 treatment, patients who had been hospitalized or treated in Intensive Care Units and who experienced cardiac complications exhibited worse mental health scores.</p><p><strong>Conclusion: </strong>The findings of this study indicate a statistically significant higher likelihood of poorer mental health among hypertensive patients who had contracted COVID-19.</p>","PeriodicalId":94128,"journal":{"name":"Materia socio-medica","volume":"37 3","pages":"231-235"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12858271/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146109343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alchemilla Vulgaris Compounds as Inhibitors of HPV 16 E6 Oncoprotein: Quercetin with Promising in Silico Potential. 紫金丹化合物作为HPV 16 E6癌蛋白抑制剂:槲皮素在硅方面的应用前景
Pub Date : 2025-01-01 DOI: 10.5455/msm.2025.37.184-190
Emir Sehercehajic, Berina Hasanefendic, Aleksandra Pasic, Emina Smajic

Background: The oncogenic potential of HPV remains a major global public health challenge and various natural therapeutics are being investigated to prevent cancer. The natural components of the Alchemilla vulgaris plant have various anti-inflammatory, antioxidant, antiviral, and anticancer effects.

Objective: Therefore, the aim of this study was to bioinformatically examine the potential inhibitory effect of A. vulgaris compounds on the HPV target protein.

Methods: The structures of quercetin, catechin, apigenin, luteolin, caffeic and gallic acid were taken from the PubChem database, and the protein structure of the target HPV 16 E6 oncoprotein (PDB ID: 4XR8) from the Protein Data Bank. Virtual screening and docking analysis were performed in AutoDock Vina. Protein-ligand complexes were visualized using Discovery Studio. The molecular dynamics simulation of 4XR8 in complex with quercetin was performed using Desmond.

Results: Docking analysis showed that quercetin has the strongest binding affinity with 4XR8 (quercetin -8.9 kcal/mol, apigenin -8.7 kcal/mol, luteolin -8.7 kcal/mol, catechin -8.4 kcal/mol, caffeic acid -7.3 kcal/mol, gallic acid -6.8 kcal/mol). The molecular dynamics simulation results reinforce the stability and strong binding affinity of quercetin within the HPV 16 E6 oncoprotein.

Conclusion: Natural components of Alchemilla vulgaris, especially quercetin, have shown promising potential for the treatment of HPV infection and additional in vitro and in vivo studies are needed for their further research.

背景:HPV的致癌潜力仍然是一个主要的全球公共卫生挑战,各种自然疗法正在研究以预防癌症。炼金术植物的天然成分具有多种抗炎、抗氧化、抗病毒和抗癌作用。目的:从生物信息学的角度考察寻常草化合物对HPV靶蛋白的潜在抑制作用。方法:槲皮素、儿茶素、芹菜素、木木草素、咖啡素和没食子酸的结构取自PubChem数据库,目标HPV 16e6癌蛋白(PDB ID: 4XR8)的蛋白质结构取自protein Data Bank。在AutoDock Vina中进行虚拟筛选和对接分析。使用Discovery Studio可视化蛋白质配体复合物。采用Desmond软件对4XR8与槲皮素配合物进行分子动力学模拟。结果:对接分析显示槲皮素与4XR8的结合亲和力最强(槲皮素-8.9 kcal/mol,芹菜素-8.7 kcal/mol,木犀草素-8.7 kcal/mol,儿茶素-8.4 kcal/mol,咖啡酸-7.3 kcal/mol,没食子酸-6.8 kcal/mol)。分子动力学模拟结果强化了槲皮素在HPV 16e6癌蛋白内的稳定性和较强的结合亲和力。结论:丹金术的天然成分特别是槲皮素在治疗HPV感染方面具有良好的潜力,还需要进一步的体内外实验研究。
{"title":"Alchemilla Vulgaris Compounds as Inhibitors of HPV 16 E6 Oncoprotein: Quercetin with Promising in Silico Potential.","authors":"Emir Sehercehajic, Berina Hasanefendic, Aleksandra Pasic, Emina Smajic","doi":"10.5455/msm.2025.37.184-190","DOIUrl":"10.5455/msm.2025.37.184-190","url":null,"abstract":"<p><strong>Background: </strong>The oncogenic potential of HPV remains a major global public health challenge and various natural therapeutics are being investigated to prevent cancer. The natural components of the Alchemilla vulgaris plant have various anti-inflammatory, antioxidant, antiviral, and anticancer effects.</p><p><strong>Objective: </strong>Therefore, the aim of this study was to bioinformatically examine the potential inhibitory effect of A. vulgaris compounds on the HPV target protein.</p><p><strong>Methods: </strong>The structures of quercetin, catechin, apigenin, luteolin, caffeic and gallic acid were taken from the PubChem database, and the protein structure of the target HPV 16 E6 oncoprotein (PDB ID: 4XR8) from the Protein Data Bank. Virtual screening and docking analysis were performed in AutoDock Vina. Protein-ligand complexes were visualized using Discovery Studio. The molecular dynamics simulation of 4XR8 in complex with quercetin was performed using Desmond.</p><p><strong>Results: </strong>Docking analysis showed that quercetin has the strongest binding affinity with 4XR8 (quercetin -8.9 kcal/mol, apigenin -8.7 kcal/mol, luteolin -8.7 kcal/mol, catechin -8.4 kcal/mol, caffeic acid -7.3 kcal/mol, gallic acid -6.8 kcal/mol). The molecular dynamics simulation results reinforce the stability and strong binding affinity of quercetin within the HPV 16 E6 oncoprotein.</p><p><strong>Conclusion: </strong>Natural components of Alchemilla vulgaris, especially quercetin, have shown promising potential for the treatment of HPV infection and additional in vitro and in vivo studies are needed for their further research.</p>","PeriodicalId":94128,"journal":{"name":"Materia socio-medica","volume":"37 3","pages":"184-190"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12858261/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146109409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Manifestation of Necrotic Palatal Ulceration in COVID-19 Infection: a Case Report. COVID-19感染后腭坏死性溃疡1例
Pub Date : 2025-01-01 DOI: 10.5455/msm.2025.37.80-82
Mimoza Canga, Alketa Qafmolla, Edit Xhajanka, Irene Malagnino

Background: The global pandemic caused by the COVID-19 virus is a serious disease that has significantly affected the lives of millions of people.

Objective: The objective of this case study is to describe the development of a necrotic ulcer on the palate in a COVID-19 patient.

Case presentation: This is the clinical case of a 35-year-old male patient with a 20-year history of two pack-a-day smoking who contracted COVID-19. He was admitted to the Department of Oral and Maxillofacial Surgery at the "Mother Teresa" University Hospital Center in Tirana, Albania, presenting with oral pain, facial swelling, and necrosis in the palatal region and the lower lip.

Conclusion: This case report from Albania is significant as it presents an ulcer with necrotic tissue located in the hard palate region of a patient infected with SARS-CoV-2.

背景:由COVID-19病毒引起的全球大流行是一种严重疾病,严重影响了数百万人的生活。目的:本病例研究的目的是描述一名COVID-19患者上颚坏死性溃疡的发展。病例介绍:这是一名35岁的男性患者,有20年的吸烟史,感染了COVID-19。他被阿尔巴尼亚地拉那“特蕾莎修女”大学医院中心的口腔颌面外科收治,表现为口腔疼痛、面部肿胀、腭区和下唇坏死。结论:来自阿尔巴尼亚的病例报告具有重要意义,因为它呈现了一名感染SARS-CoV-2的患者硬腭区溃疡伴坏死组织。
{"title":"Manifestation of Necrotic Palatal Ulceration in COVID-19 Infection: a Case Report.","authors":"Mimoza Canga, Alketa Qafmolla, Edit Xhajanka, Irene Malagnino","doi":"10.5455/msm.2025.37.80-82","DOIUrl":"10.5455/msm.2025.37.80-82","url":null,"abstract":"<p><strong>Background: </strong>The global pandemic caused by the COVID-19 virus is a serious disease that has significantly affected the lives of millions of people.</p><p><strong>Objective: </strong>The objective of this case study is to describe the development of a necrotic ulcer on the palate in a COVID-19 patient.</p><p><strong>Case presentation: </strong>This is the clinical case of a 35-year-old male patient with a 20-year history of two pack-a-day smoking who contracted COVID-19. He was admitted to the Department of Oral and Maxillofacial Surgery at the \"Mother Teresa\" University Hospital Center in Tirana, Albania, presenting with oral pain, facial swelling, and necrosis in the palatal region and the lower lip.</p><p><strong>Conclusion: </strong>This case report from Albania is significant as it presents an ulcer with necrotic tissue located in the hard palate region of a patient infected with SARS-CoV-2.</p>","PeriodicalId":94128,"journal":{"name":"Materia socio-medica","volume":"37 1","pages":"80-82"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11910900/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143652814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Diagnostic Significance of the Tumor Marker CYFRA 21-1 in Patients with Laryngeal Carcinoma. 肿瘤标志物CYFRA 21-1在喉癌诊断中的意义。
Pub Date : 2025-01-01 DOI: 10.5455/msm.2025.37.131-135
Lejla Tokic, Sefik Hasukic, Fuad Brkic, Sekib Umihanic, Fatima Hukic, Selveta Mustafic

Background: Laryngeal squamous cell carcinoma (LSC) is the leading malignant tumour of the head and neck. Establishing new biomarkers is extremely important because they can be important for early diagnosis and prognosis of LSC.

Objective: The aim of this study was to establish the significance of cytokeratin fragment antigen 21-1 (CYFRA 21-1) in the early diagnosis and prognosis of LSC.

Methods: This was prospective research involving 35 patients of both sexes with pathohistologically confirmed LSC, who were treated in the period from 2022 to 2024. The control group consisted of 30 patients who underwent surgery for other non-malignant diseases and who had a normal indirect laryngoscopy findings. The levels of CYFRA 21-1 were determined for three time periods: preoperative, four weeks after surgery, and three months after radiotherapy or concomitant chemoradiotherapy. For the statistical analysis of data we used descriptive statistics methods, the Student T-test and the χ2 test to calculate the significance of the tested differences, where differences on the level of p<0.05 were considered to be statistically significant.

Results: Statistically significantly higher mean serum levels of CYFRA 21-1 were found preoperatively in the experimental group in comparison with the control group (p<0.001). Statistically significant lower levels of CYFRA 21-1 were found four weeks after surgery in the experimental group in comparison with preoperative levels (p=0.004). A statistically significant decrease in serum levels of CYFRA 21-1 was also found three months after radiotherapy or concomitant chemoradiotherapy in comparison with the preoperative levels (p=0.001). The serum levels of CYFRA 21-1 were statistically significantly higher preoperatively in patients with stage III/IV of the disease in comparison with stage I/II (p<0.001).

Conclusion: Increased levels of CYFRA 21-1 are a significant indication of the presence of LSC, especially in patients with advanced stages of the disease.

背景:喉鳞癌(喉鳞癌)是头颈部最主要的恶性肿瘤。建立新的生物标志物对LSC的早期诊断和预后具有重要意义。目的:探讨细胞角蛋白片段抗原21-1 (CYFRA 21-1)在LSC早期诊断及预后中的意义。方法:前瞻性研究纳入35例经病理证实的LSC患者,患者性别不限,于2022年至2024年接受治疗。对照组包括30名因其他非恶性疾病而接受手术且间接喉镜检查结果正常的患者。CYFRA 21-1的水平在术前、术后4周、放疗或同期放化疗后3个月三个时间段进行测定。对资料进行统计分析时,采用描述性统计方法、学生t检验和χ2检验计算检验差异的显著性,其中差异在水平上的差异结果:实验组术前血清CYFRA 21-1平均水平显著高于对照组(p结论:CYFRA 21-1水平升高是LSC存在的重要指标,特别是在疾病晚期患者中。
{"title":"The Diagnostic Significance of the Tumor Marker CYFRA 21-1 in Patients with Laryngeal Carcinoma.","authors":"Lejla Tokic, Sefik Hasukic, Fuad Brkic, Sekib Umihanic, Fatima Hukic, Selveta Mustafic","doi":"10.5455/msm.2025.37.131-135","DOIUrl":"10.5455/msm.2025.37.131-135","url":null,"abstract":"<p><strong>Background: </strong>Laryngeal squamous cell carcinoma (LSC) is the leading malignant tumour of the head and neck. Establishing new biomarkers is extremely important because they can be important for early diagnosis and prognosis of LSC.</p><p><strong>Objective: </strong>The aim of this study was to establish the significance of cytokeratin fragment antigen 21-1 (CYFRA 21-1) in the early diagnosis and prognosis of LSC.</p><p><strong>Methods: </strong>This was prospective research involving 35 patients of both sexes with pathohistologically confirmed LSC, who were treated in the period from 2022 to 2024. The control group consisted of 30 patients who underwent surgery for other non-malignant diseases and who had a normal indirect laryngoscopy findings. The levels of CYFRA 21-1 were determined for three time periods: preoperative, four weeks after surgery, and three months after radiotherapy or concomitant chemoradiotherapy. For the statistical analysis of data we used descriptive statistics methods, the Student T-test and the χ2 test to calculate the significance of the tested differences, where differences on the level of p<0.05 were considered to be statistically significant.</p><p><strong>Results: </strong>Statistically significantly higher mean serum levels of CYFRA 21-1 were found preoperatively in the experimental group in comparison with the control group (p<0.001). Statistically significant lower levels of CYFRA 21-1 were found four weeks after surgery in the experimental group in comparison with preoperative levels (p=0.004). A statistically significant decrease in serum levels of CYFRA 21-1 was also found three months after radiotherapy or concomitant chemoradiotherapy in comparison with the preoperative levels (p=0.001). The serum levels of CYFRA 21-1 were statistically significantly higher preoperatively in patients with stage III/IV of the disease in comparison with stage I/II (p<0.001).</p><p><strong>Conclusion: </strong>Increased levels of CYFRA 21-1 are a significant indication of the presence of LSC, especially in patients with advanced stages of the disease.</p>","PeriodicalId":94128,"journal":{"name":"Materia socio-medica","volume":"37 2","pages":"131-135"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12212222/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144556319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aphasia in Patients with Intracranial Tumors. 颅内肿瘤患者的失语。
Pub Date : 2025-01-01 DOI: 10.5455/msm.2025.37.220-223
Jasmina Klebic, Mirela Duranovic, Emir Tupkovic, Rusmir Softić, Senada Selmanović, Anida Sehanovic, Amila Tokic, Nedim Srabovic

Background: Aphasia is an acquired communication disorder that affects language comprehension and production, typically occurring after brain damage. It is a frequent clinical manifestation of both benign and malignant brain tumors, particularly when lesions are localized in language-dominant areas.

Objective: To assess the prevalence and characterize the types of aphasia in patients with intracranial tumors, emphasizing its clinical significance and the importance of early speech-language evaluation.

Methods: This prospective study included patients with confirmed brain tumors diagnosed through neuroimaging (CT or MRI of the neurocranium), who were hospitalized at the Clinic of Neurosurgery, University Clinical Center Tuzla, over a one-year period. Patients with pre-existing aphasia of any etiology, as well as those who had not acquired reading and writing skills, were excluded. All assessments were performed prior to surgical intervention using the Boston Diagnostic Aphasia Examination.

Results: Aphasia was diagnosed in 25 patients (27.5%). The most common type was anomic aphasia in 10 patients (40%), followed by Broca's aphasia in 7 patients (28%), transcortical motor aphasia in 3 patients (12%), and transcortical sensory aphasia in 1 patient (4%). The highest number of patients with aphasia had tumors localized in the left temporal lobe, followed by the parietal and temporoparietal regions.

Conclusion: Aphasia is a common clinical finding in patients with intracranial tumors, affecting more than one-quarter of the studied population. The distribution of aphasia types is consistent with the localization of lesions in language-dominant areas, particularly the left temporal lobe. Early recognition and detailed speech-language assessment are essential for timely intervention, rehabilitation planning, and optimizing functional outcomes.

背景:失语症是一种影响语言理解和产生的后天交流障碍,通常发生在脑损伤后。它是良性和恶性脑肿瘤的常见临床表现,特别是当病变局限于语言优势区域时。目的:了解颅内肿瘤患者失语的患病率及类型特点,强调其临床意义及早期言语语言评价的重要性。方法:本前瞻性研究纳入了在图兹拉大学临床中心神经外科诊所住院一年以上的经神经影像学(颅脑CT或MRI)确诊的脑肿瘤患者。已存在任何病因的失语症患者,以及未获得阅读和写作技能的患者均被排除在外。所有评估均在手术干预前使用波士顿诊断性失语检查进行。结果:失语25例(27.5%)。最常见的失语症类型为名称型失语症(10例)(40%),其次为布罗卡失语症(7例)(28%),经皮质运动失语症(3例)(12%),经皮质感觉失语症(1例)(4%)。失语症患者肿瘤位于左侧颞叶最多,其次是顶叶和颞顶叶。结论:失语是颅内肿瘤患者的常见临床表现,影响超过四分之一的研究人群。失语症类型的分布与语言优势区,特别是左颞叶病变的定位一致。早期识别和详细的言语语言评估对于及时干预、康复计划和优化功能结果至关重要。
{"title":"Aphasia in Patients with Intracranial Tumors.","authors":"Jasmina Klebic, Mirela Duranovic, Emir Tupkovic, Rusmir Softić, Senada Selmanović, Anida Sehanovic, Amila Tokic, Nedim Srabovic","doi":"10.5455/msm.2025.37.220-223","DOIUrl":"10.5455/msm.2025.37.220-223","url":null,"abstract":"<p><strong>Background: </strong>Aphasia is an acquired communication disorder that affects language comprehension and production, typically occurring after brain damage. It is a frequent clinical manifestation of both benign and malignant brain tumors, particularly when lesions are localized in language-dominant areas.</p><p><strong>Objective: </strong>To assess the prevalence and characterize the types of aphasia in patients with intracranial tumors, emphasizing its clinical significance and the importance of early speech-language evaluation.</p><p><strong>Methods: </strong>This prospective study included patients with confirmed brain tumors diagnosed through neuroimaging (CT or MRI of the neurocranium), who were hospitalized at the Clinic of Neurosurgery, University Clinical Center Tuzla, over a one-year period. Patients with pre-existing aphasia of any etiology, as well as those who had not acquired reading and writing skills, were excluded. All assessments were performed prior to surgical intervention using the Boston Diagnostic Aphasia Examination.</p><p><strong>Results: </strong>Aphasia was diagnosed in 25 patients (27.5%). The most common type was anomic aphasia in 10 patients (40%), followed by Broca's aphasia in 7 patients (28%), transcortical motor aphasia in 3 patients (12%), and transcortical sensory aphasia in 1 patient (4%). The highest number of patients with aphasia had tumors localized in the left temporal lobe, followed by the parietal and temporoparietal regions.</p><p><strong>Conclusion: </strong>Aphasia is a common clinical finding in patients with intracranial tumors, affecting more than one-quarter of the studied population. The distribution of aphasia types is consistent with the localization of lesions in language-dominant areas, particularly the left temporal lobe. Early recognition and detailed speech-language assessment are essential for timely intervention, rehabilitation planning, and optimizing functional outcomes.</p>","PeriodicalId":94128,"journal":{"name":"Materia socio-medica","volume":"37 3","pages":"220-223"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12858259/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146109383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Public Awareness of Corticosteroid Use and Side Effects: a Cross-Sectional Study from Jordan. 公众对皮质类固醇使用及其副作用的认识:一项来自约旦的横断面研究。
Pub Date : 2025-01-01 DOI: 10.5455/msm.2025.37.24-31
Sufian M Rifaei, Shahd Etoom, Suzan Adel Hanandeh, Sara Haj Ali, Aroob Mohammad Alzboon, Mohammad Dakhil Al-Jaraideh, Shatha Aktham, Kamal Khaled Moh'd Hamad, Mohamad Alharoun, Ahed J Alkhatib

Background: Corticosteroid usage is very widespread these days. However, the way corticosteroids are administered, the side effects of the drug and the risks associated with its usage are not widely known.

Objective: The authors evaluated the responses of a diverse group who were aware of the methods of corticosteroid administration, side effects and information provided by the health care provider. To assess the awareness level and identify the gaps in knowledge descriptive statistics were used.

Methods: The study was a cross sectional online survey conducted during July and December of 2024 using non-probability convenience sampling. A collection of queries were used to test knowledge of steroids as well as its effects. The sample included Jordanians aged 18 and above. The data was analyzed using logistic regression and chi-square with the SPSS (version 27).

Results: From the participants, it was seen that 39.8% used corticosteroids. The most recognized were the oral (81%) and intravenous (60.9%). Most commonly noticed side effects were weight gain (81%) and mood swings (45.9%), rare ones being anemia (7%) and epilepsy (4.3%) were less known. There was high awareness about corticosteroid use in respiratory illnesses like asthma (71%) and autoimmune conditions like rheumatoid disease (64%), but awareness about their use in metabolic and oncological diseases was limited. Only 40.9% of participants said that side effects info was provided to them.

Conclusion: There were significant gaps in community awareness which might compromise the therapeutic utility of corticosteroids.

背景:近年来皮质类固醇的使用非常广泛。然而,皮质类固醇的使用方式、药物的副作用以及与使用相关的风险尚不为人所知。目的:作者评估了了解皮质类固醇给药方法、副作用和卫生保健提供者提供的信息的不同群体的反应。为了评估意识水平并确定知识差距,使用了描述性统计。方法:采用非概率方便抽样方法,于2024年7月至12月进行横断面在线调查。一系列的问题被用来测试人们对类固醇及其作用的了解。样本包括18岁及以上的约旦人。使用SPSS (version 27)对数据进行logistic回归和卡方分析。结果:39.8%的受试者使用皮质激素。认识最多的是口服(81%)和静脉注射(60.9%)。最常见的副作用是体重增加(81%)和情绪波动(45.9%),罕见的副作用是贫血(7%)和癫痫(4.3%),鲜为人知。人们对皮质类固醇在呼吸系统疾病如哮喘(71%)和自身免疫性疾病如类风湿疾病(64%)中的使用有很高的认识,但对其在代谢和肿瘤疾病中的使用的认识有限。只有40.9%的参与者说他们得到了副作用信息。结论:社区对糖皮质激素的认知存在明显差距,这可能会影响糖皮质激素的治疗效果。
{"title":"Public Awareness of Corticosteroid Use and Side Effects: a Cross-Sectional Study from Jordan.","authors":"Sufian M Rifaei, Shahd Etoom, Suzan Adel Hanandeh, Sara Haj Ali, Aroob Mohammad Alzboon, Mohammad Dakhil Al-Jaraideh, Shatha Aktham, Kamal Khaled Moh'd Hamad, Mohamad Alharoun, Ahed J Alkhatib","doi":"10.5455/msm.2025.37.24-31","DOIUrl":"10.5455/msm.2025.37.24-31","url":null,"abstract":"<p><strong>Background: </strong>Corticosteroid usage is very widespread these days. However, the way corticosteroids are administered, the side effects of the drug and the risks associated with its usage are not widely known.</p><p><strong>Objective: </strong>The authors evaluated the responses of a diverse group who were aware of the methods of corticosteroid administration, side effects and information provided by the health care provider. To assess the awareness level and identify the gaps in knowledge descriptive statistics were used.</p><p><strong>Methods: </strong>The study was a cross sectional online survey conducted during July and December of 2024 using non-probability convenience sampling. A collection of queries were used to test knowledge of steroids as well as its effects. The sample included Jordanians aged 18 and above. The data was analyzed using logistic regression and chi-square with the SPSS (version 27).</p><p><strong>Results: </strong>From the participants, it was seen that 39.8% used corticosteroids. The most recognized were the oral (81%) and intravenous (60.9%). Most commonly noticed side effects were weight gain (81%) and mood swings (45.9%), rare ones being anemia (7%) and epilepsy (4.3%) were less known. There was high awareness about corticosteroid use in respiratory illnesses like asthma (71%) and autoimmune conditions like rheumatoid disease (64%), but awareness about their use in metabolic and oncological diseases was limited. Only 40.9% of participants said that side effects info was provided to them.</p><p><strong>Conclusion: </strong>There were significant gaps in community awareness which might compromise the therapeutic utility of corticosteroids.</p>","PeriodicalId":94128,"journal":{"name":"Materia socio-medica","volume":"37 1","pages":"24-31"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11910899/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143652872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frequency of Fals and Degree of Diability in Stroke Patients. 卒中患者跌倒频率与残疾程度的关系。
Pub Date : 2025-01-01 DOI: 10.5455/msm.2025.37.164-168
Zikrija Dostovic, Nermin Mesic, Mirza Moranjkic, Hasad Imamovic, Suljo Kunic, Denisa Salihovic, Kenan Galijasevic

Background: Stroke patients have significant disability and an increased risk of falling.

Objective: To determine the incidence of falls and the degree of disability in stroke patients and to determine the correlation of falls with the degree of disability.

Methods: This is a prospective study of 100 stroke patients confirmed by computed tomography and magnetic resonance imaging of the brain. We used a demographic questionnaire together with the Glasgow Coma Scale, Stroke Assessment Scale, Rankin Scale and Morse Scale to collect data and analyzed them using SPSS 17, including statistical measures, including Pearson correlation.

Results: Hemorrhagic stroke patients had a higher incidence of falls (p = 0.06). There was no difference in the incidence of falls according to the gender of the patients (p = 0.07). Older people had a higher frequency of falls, and women and patients with hemorrhagic stroke had a higher risk of falling (p = 0.2). Patients with a stroke in the area of the anterior circulation were statistically significantly more disabled (p < 0.05). A weak positive correlation was calculated between the frequency of falls of patients after stroke and the degree of disability (r = 0.08, n = 94, p = 0.4). Stroke patients who also had atrial fibrillation as a comorbidity had a statistically significantly higher frequency of falls compared to patients with other comorbidities (p = 0.02).

Conclusion: Patients with hemorrhagic stroke have a higher frequency of falls. Women, elderly people, patients with a stroke in the area of the anterior circulation and with atrial fibrillation as a comorbidity are statistically significantly more disabled after a stroke. There is a positive correlation between the frequency of falls in patients after a stroke and the degree of disability.

背景:脑卒中患者有明显的残疾和摔倒的风险增加。目的:了解脑卒中患者跌倒的发生率与残疾程度,确定跌倒与残疾程度的相关性。方法:对100例脑卒中患者进行前瞻性研究,经计算机断层扫描和脑磁共振成像证实。我们采用人口统计问卷,结合格拉斯哥昏迷量表、卒中评估量表、Rankin量表和Morse量表收集数据,并使用SPSS 17进行分析,包括统计学测量,包括Pearson相关。结果:出血性脑卒中患者跌倒发生率较高(p = 0.06)。不同性别患者的跌倒发生率无差异(p = 0.07)。老年人摔倒的频率更高,女性和出血性中风患者摔倒的风险更高(p = 0.2)。卒中患者前循环区功能障碍明显加重(p < 0.05)。脑卒中后跌倒频率与残疾程度呈弱正相关(r = 0.08, n = 94, p = 0.4)。合并房颤的卒中患者跌倒的频率明显高于合并其他合并症的患者(p = 0.02)。结论:出血性脑卒中患者有较高的跌倒发生率。女性、老年人、前循环中风患者和合并房颤的患者在中风后残疾的发生率在统计上显著增加。中风后跌倒的频率与残疾程度呈正相关。
{"title":"Frequency of Fals and Degree of Diability in Stroke Patients.","authors":"Zikrija Dostovic, Nermin Mesic, Mirza Moranjkic, Hasad Imamovic, Suljo Kunic, Denisa Salihovic, Kenan Galijasevic","doi":"10.5455/msm.2025.37.164-168","DOIUrl":"10.5455/msm.2025.37.164-168","url":null,"abstract":"<p><strong>Background: </strong>Stroke patients have significant disability and an increased risk of falling.</p><p><strong>Objective: </strong>To determine the incidence of falls and the degree of disability in stroke patients and to determine the correlation of falls with the degree of disability.</p><p><strong>Methods: </strong>This is a prospective study of 100 stroke patients confirmed by computed tomography and magnetic resonance imaging of the brain. We used a demographic questionnaire together with the Glasgow Coma Scale, Stroke Assessment Scale, Rankin Scale and Morse Scale to collect data and analyzed them using SPSS 17, including statistical measures, including Pearson correlation.</p><p><strong>Results: </strong>Hemorrhagic stroke patients had a higher incidence of falls (p = 0.06). There was no difference in the incidence of falls according to the gender of the patients (p = 0.07). Older people had a higher frequency of falls, and women and patients with hemorrhagic stroke had a higher risk of falling (p = 0.2). Patients with a stroke in the area of the anterior circulation were statistically significantly more disabled (p < 0.05). A weak positive correlation was calculated between the frequency of falls of patients after stroke and the degree of disability (r = 0.08, n = 94, p = 0.4). Stroke patients who also had atrial fibrillation as a comorbidity had a statistically significantly higher frequency of falls compared to patients with other comorbidities (p = 0.02).</p><p><strong>Conclusion: </strong>Patients with hemorrhagic stroke have a higher frequency of falls. Women, elderly people, patients with a stroke in the area of the anterior circulation and with atrial fibrillation as a comorbidity are statistically significantly more disabled after a stroke. There is a positive correlation between the frequency of falls in patients after a stroke and the degree of disability.</p>","PeriodicalId":94128,"journal":{"name":"Materia socio-medica","volume":"37 2","pages":"164-168"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12212237/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144556311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Anticoagulant Therapy as a Treatment for Pulmonary Thromboembolism in Patients During the COVID-19 Epidemic. 新型抗凝治疗新冠肺炎流行期间肺血栓栓塞的研究
Pub Date : 2025-01-01 DOI: 10.5455/msm.2025.37.144-148
Amar Terzimehic, Muhamed Skomorac, Lejla Hindija, Elma Kuduzovic

Background: Pulmonary embolism is a frequent, serious and life-threatening complication that represents the embolization of mostly thrombotic material into the pulmonary arteries, with complete or partial occlusion of one or more of its branches.

Objective: To analyze the effectiveness of new anticoagulants (NOAC) in the long-term treatment of pulmonary embolism (PE) in patients with and without COVID-19.

Methods: Retrospective and descriptive analysis based on data from medical records in the period 2021-2023. from the Zenica Cantonal Hospital.

Results: Data were collected from 160 respondents, of which 33 (20.6%) were COVID-19 positive and 127 (79.4%) were not. Subjects with COVID-19 in 12 (36.4%) cases had reference D-dimer values, while 21 (63.6%) had elevated values. 9.1% had elevated platelet values, 78.8% had reference values, and 12.1% had decreased values. Among subjects without COVID-19, 50 (39.4%) had reference values of D-dimer, while 77 (60.6%) had an increase. 1 (0.8%) of subjects had decreased platelet values, 118 (92.9%) had reference values, and 8 (6.3%) had increased platelet values. No subjects with decreased D-dimer values were recorded.

Conclusion: DOAC therapy showed equal efficacy in the long-term treatment of pulmonary embolism in both study groups, regardless of whether the subjects had COVID-19 or not.

背景:肺栓塞是一种常见的、严重的、危及生命的并发症,主要表现为血栓性物质栓塞进入肺动脉,并完全或部分阻塞其一个或多个分支。目的:分析新型抗凝剂(NOAC)长期治疗合并和未合并COVID-19患者肺栓塞(PE)的疗效。方法:采用回顾性和描述性分析方法,对2021-2023年的病案资料进行分析。泽尼察州立医院结果:160例被调查者中,新冠病毒阳性33例(20.6%),阴性127例(79.4%)。12例(36.4%)新冠肺炎患者的参考d -二聚体值升高,21例(63.6%)患者的参考d -二聚体值升高。9.1%的患者血小板值升高,78.8%的患者血小板值有参考值,12.1%的患者血小板值下降。无COVID-19的受试者中,d -二聚体参考值有50例(39.4%),升高77例(60.6%)。血小板值降低1例(0.8%),有参考值118例(92.9%),血小板值升高8例(6.3%)。未记录d -二聚体值降低的受试者。结论:无论受试者是否患有COVID-19, DOAC治疗在两个研究组中长期治疗肺栓塞的疗效相同。
{"title":"New Anticoagulant Therapy as a Treatment for Pulmonary Thromboembolism in Patients During the COVID-19 Epidemic.","authors":"Amar Terzimehic, Muhamed Skomorac, Lejla Hindija, Elma Kuduzovic","doi":"10.5455/msm.2025.37.144-148","DOIUrl":"10.5455/msm.2025.37.144-148","url":null,"abstract":"<p><strong>Background: </strong>Pulmonary embolism is a frequent, serious and life-threatening complication that represents the embolization of mostly thrombotic material into the pulmonary arteries, with complete or partial occlusion of one or more of its branches.</p><p><strong>Objective: </strong>To analyze the effectiveness of new anticoagulants (NOAC) in the long-term treatment of pulmonary embolism (PE) in patients with and without COVID-19.</p><p><strong>Methods: </strong>Retrospective and descriptive analysis based on data from medical records in the period 2021-2023. from the Zenica Cantonal Hospital.</p><p><strong>Results: </strong>Data were collected from 160 respondents, of which 33 (20.6%) were COVID-19 positive and 127 (79.4%) were not. Subjects with COVID-19 in 12 (36.4%) cases had reference D-dimer values, while 21 (63.6%) had elevated values. 9.1% had elevated platelet values, 78.8% had reference values, and 12.1% had decreased values. Among subjects without COVID-19, 50 (39.4%) had reference values of D-dimer, while 77 (60.6%) had an increase. 1 (0.8%) of subjects had decreased platelet values, 118 (92.9%) had reference values, and 8 (6.3%) had increased platelet values. No subjects with decreased D-dimer values were recorded.</p><p><strong>Conclusion: </strong>DOAC therapy showed equal efficacy in the long-term treatment of pulmonary embolism in both study groups, regardless of whether the subjects had COVID-19 or not.</p>","PeriodicalId":94128,"journal":{"name":"Materia socio-medica","volume":"37 2","pages":"144-148"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12212239/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144556313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Materia socio-medica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1